James M Mock is Chief Financial Officer of Moderna, Inc.. Currently has a direct ownership of 7,269 shares of MRNA, which is worth approximately $629,858. The most recent transaction as insider was on Jul 08, 2024, when has been sold 689 shares (Common Stock) at a price of $118.24 per share, resulting in proceeds of $81,467. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.27K
44.0% 3M change
n/a 12M change
Total Value Held $629,858

James M Mock Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 08 2024
SELL
Open market or private sale
$81,467 $118.24 p/Share
689 Reduced 8.66%
7,269 Common Stock
Jul 05 2024
BUY
Exercise of conversion of derivative security
-
1,452 Added 15.43%
7,958 Common Stock
Jun 03 2024
SELL
Open market or private sale
$97,237 $140.72 p/Share
691 Reduced 9.6%
6,506 Common Stock
May 31 2024
BUY
Exercise of conversion of derivative security
-
1,326 Added 15.56%
7,197 Common Stock
May 29 2024
SELL
Open market or private sale
$26,443 $144.5 p/Share
183 Reduced 3.02%
5,871 Common Stock
May 28 2024
SELL
Open market or private sale
$105,280 $162.47 p/Share
648 Reduced 10.17%
5,726 Common Stock
May 28 2024
BUY
Exercise of conversion of derivative security
-
328 Added 5.14%
6,054 Common Stock
May 24 2024
BUY
Exercise of conversion of derivative security
-
1,326 Added 17.22%
6,374 Common Stock
Apr 08 2024
SELL
Open market or private sale
$71,860 $101.93 p/Share
705 Reduced 12.25%
5,048 Common Stock
Apr 05 2024
BUY
Exercise of conversion of derivative security
-
1,453 Added 20.16%
5,753 Common Stock
Feb 29 2024
SELL
Open market or private sale
$61,186 $94.57 p/Share
647 Reduced 13.08%
4,300 Common Stock
Feb 28 2024
BUY
Exercise of conversion of derivative security
-
1,315 Added 21.0%
4,947 Common Stock
Jan 08 2024
SELL
Open market or private sale
$84,727 $109.75 p/Share
772 Reduced 17.53%
3,632 Common Stock
Jan 05 2024
BUY
Exercise of conversion of derivative security
-
1,452 Added 24.8%
4,404 Common Stock
Oct 06 2023
SELL
Open market or private sale
$292,945 $102.5 p/Share
2,858 Reduced 49.19%
2,952 Common Stock
Oct 05 2023
BUY
Exercise of conversion of derivative security
-
5,810 Added 50.0%
5,810 Common Stock

Also insider at

PKI
PERKINELMER INC Healthcare
JMM

James M Mock

Chief Financial Officer
Waltham, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA